Bcl-2 inhibition combined with PPARα activation synergistically targets leukemic stem cell-like cells in acute myeloid leukemia
Chendi Xie(Xiamen University), Jie Zha(Xiamen University)
Cited by 14
Related Papers
Therapeutic Activation of PPARα Inhibits Transformed Follicular Lymphoma Tumorigenesis via the FOXM1 Signaling Pathway
|International Journal of Biological Sciences|2025|2
Venetoclax confers synthetic lethality to chidamide in preclinical models with transformed follicular lymphoma
|Clinical Epigenetics|2025|1